L-DOPA-induced dopamine release in substantia nigra in hemi-parkinson rats: Effects of muscarinic antagonists

被引：0
|
作者：
Sarre, S
Izurieta-Sanchez, P
Ebinger, G
Michotte, Y
机构：
[1] Free Univ Brussels, Dept Pharmaceut Chem & Drug Anal, Brussels, Belgium
[2] Free Univ Brussels, Dept Neurol, Brussels, Belgium
来源：
EUROPEAN JOURNAL OF NEUROSCIENCE | 2000年 / 12卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：217 / 217
页数：1
相关论文
共 50 条
  • [21] Protein expression levels and activity of the glial glutamate transporters in the substantia nigra pars reticulata and striatum of 6-hydroxydopamine hemi-Parkinson rats
    Massie, A.
    Mertens, B.
    Arckens, L.
    Sarre, S.
    Michotte, Y.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S126 - S127
  • [22] Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia
    Nevalainen, Nina
    af Bjerken, Sara
    Lundblad, Martin
    Gerhardt, Greg A.
    Stromberg, Ingrid
    JOURNAL OF NEUROCHEMISTRY, 2011, 118 (01) : 12 - 23
  • [23] L-Dopa-induced adverse effects in PD and dopamine transporter gene polymorphism
    Kaiser, R
    Hofer, A
    Grapengiesser, A
    Gasser, T
    Kupsch, A
    Roots, I
    Brockmöller, J
    NEUROLOGY, 2003, 60 (11) : 1750 - 1755
  • [24] Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats
    Barnum, Christopher J.
    Bhide, Nirmal
    Lindenbach, David
    Surrena, Margaret A.
    Goldenberg, Adam A.
    Tignor, Stefanie
    Klioueva, Anna
    Walters, Hannah
    Bishop, Christopher
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2012, 100 (03) : 607 - 615
  • [25] Effect of tricyclic antidepressants on L-DOPA-induced dyskinesia and motor improvement in hemi-parkinsonian rats
    Conti, Melissa M.
    Goldenberg, Adam A. A.
    Kuberka, Alexandra
    Mohamed, Mohamed
    Eissa, Satie
    Lindenbach, David
    Bishop, Christopher
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2016, 142 : 64 - 71
  • [26] Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa-Induced Dyskinesia in Parkinson's Disease
    Comi, Cristoforo
    Ferrari, Marco
    Marino, Franca
    Magistrelli, Luca
    Cantello, Roberto
    Riboldazzi, Giulio
    Bianchi, Maria Laura Ester
    Bono, Giorgio
    Cosentino, Marco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (02)
  • [27] Beneficial effects of amantadine on L-Dopa-induced dyskinesias in Parkinson's disease
    Luginger, E
    Wenning, GK
    Bösch, S
    Poewe, W
    MOVEMENT DISORDERS, 2000, 15 (05) : 873 - 878
  • [28] DOPAMINE OUTPUT DURING L-DOPA INFUSION INTO THE SUBSTANTIA-NIGRA OF RESERPINISED RATS IS AUGMENTED BY DIZOCILPINE
    BIGGS, CS
    FOWLER, LJ
    WHITTON, PS
    STARR, MS
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 : P26 - P26
  • [29] Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats
    Conti, Melissa M.
    Ostock, Corinne Y.
    Lindenbach, David
    Goldenberg, Adam A.
    Kampton, Elias
    Dell'isola, Rich
    Katzman, Aaron C.
    Bishop, Christopher
    NEUROPHARMACOLOGY, 2014, 77 : 1 - 8
  • [30] COMPARISON OF EFFECTS OF DECARBOXYLASE INHIBITORS ON L-DOPA-INDUCED CIRCLING BEHAVIOR AND CONVERSION OF DOPA TO DOPAMINE IN BRAIN
    GOODALE, DB
    MOORE, KE
    LIFE SCIENCES, 1976, 19 (05) : 701 - 706
12345